Abiopharma

(99% Neutral) COEPTIS THERAPEUTICS HOLDINGS, INC. (ZSQR) Announces Business Combination

📋 ABHMC II, LLC (Shareholder) plans to sell 100K shares of Immunome, Inc. (at $21.04 each, total $2.1M) Filed: Jun 30, 2026 | ID: 046298

(99% Neutral) SWARMER, INC (SWMR) Announces Business Combination

📋 Arsenal Bridge Venture II-B, LLC (Shareholder) plans to sell 1K shares of Immunome, Inc. (at $21.04 each, total $22K) Filed: Jun 30, 2026 | ID: 046297

Almstead Neil Gregory 🟡 adjusted position in 8.1K shares (2 derivative) of PTC THERAPEUTICS, INC. (PTCT) at $85.26 ($1.3M) Transaction Date: Jun 26, 2026 | Filing ID: 000019

Berg Aaron 🟡 adjusted position in 9.3K shares (1 derivative) of AMARIN CORP PLC\UK (AMRN) at $16.35 Transaction Date: Jun 26, 2026 | Filing ID: 290834

(99% Neutral) KAIROS PHARMA, LTD. (KAPA) Announces Regulatory Update

(99% Positive) BIOAFFINITY TECHNOLOGIES, INC. (BIAFW) Announces Clinical Development Update

(99% Neutral) GETTY IMAGES HOLDINGS, INC. (GETY) Announces Business Combination

Director WEISLER DION J 🟢 acquired 73 shares (1 derivative) of THERMO FISHER SCIENTIFIC INC. (TMO) Transaction Date: Jun 27, 2026 | Filing ID: 000134